WallStSmart

Lineage, Inc. Common Stock (LINE)vsModiv Inc (MDV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 11179% more annual revenue ($5.36B vs $47.48M). MDV leads profitability with a 3.0% profit margin vs -1.9%. MDV earns a higher WallStSmart Score of 40/100 (D).

LINE

Hold

36

out of 100

Grade: F

Growth: 3.3Profit: 3.5Value: 5.0Quality: 3.8
Piotroski: 5/9Altman Z: 0.81

MDV

Hold

40

out of 100

Grade: D

Growth: 4.0Profit: 5.5Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

MDV2 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Operating MarginProfitability
42.7%10/10

Strong operational efficiency at 42.7%

Areas to Watch

LINE4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-1.2%2/10

ROE of -1.2% — below average capital efficiency

Revenue GrowthGrowth
-0.2%2/10

Revenue declined 0.2%

Altman Z-ScoreHealth
0.812/10

Distress zone — elevated risk

MDV4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
1.8%4/10

1.8% revenue growth

Market CapQuality
$145.60M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.4%3/10

ROE of 0.4% — below average capital efficiency

Profit MarginProfitability
3.0%3/10

3.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : MDV

The strongest argument for MDV centers on Price/Book, Operating Margin.

Bear Case : LINE

The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.

Bear Case : MDV

The primary concerns for MDV are Revenue Growth, Market Cap, Return on Equity. Thin 3.0% margins leave little buffer for downturns.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while MDV is a value play — different risk/reward profiles.

MDV is growing revenue faster at 1.8% — sustainability is the question.

LINE generates stronger free cash flow (78M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDV scores higher overall (40/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company at the forefront of regenerative medicine, specializing in the development of advanced cell therapy solutions aimed at treating severe diseases such as eye disorders, spinal cord injuries, and cancer. Leveraging proprietary technologies and a strong commitment to strategic partnerships, the company is dedicated to revolutionizing patient care with its novel therapeutic approaches. As Lineage continues to enhance its diverse product pipeline and accelerate clinical research initiatives, it represents a compelling opportunity for institutional investors looking to support transformative advancements in healthcare.

Visit Website →

Modiv Inc

REAL ESTATE · REIT - INDUSTRIAL · USA

Modiv Inc (MDV) is a prominent real estate investment trust (REIT) specializing in the acquisition and management of single-tenant, net lease properties across the United States, primarily focusing on essential and creditworthy businesses. With a strategic emphasis on long-term lease agreements, Modiv aims to generate stable income streams while providing opportunities for capital appreciation. The company's disciplined investment strategy, along with its commitment to sustainability and innovation, positions it as a leader in the real estate sector, delivering attractive risk-adjusted returns to its investors.

Want to dig deeper into these stocks?